Drugs / 177Lu-JH04
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06636617 | Aug 2024 → Aug 2025 overdue | — | First Affiliated Hospital of Fujian Medical University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 177Lu-JH04 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06636617 ↗ |
| Route | Intravenous | “were intravenous injected” NCT06636617 ↗ |
| Target | FAP | “targeting FAP” NCT06636617 ↗ |